Oman Deep Brain Stimulation Parkinsons Disease Market Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
Description
Oman Deep Brain Stimulation Parkinsons Disease Market Overview
The Oman Deep Brain Stimulation market is valued at USD 40 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of Parkinson's disease, the growing burden of neurological disorders in the Middle East, advancements in deep brain stimulation devices (such as rechargeable and directional leads), and rising awareness about neuromodulation treatment options among patients and healthcare providers. Muscat and Dhofar are the dominant regions in the Oman Deep Brain Stimulation market due to their advanced healthcare infrastructure and the presence of tertiary and university hospitals that provide neurology and neurosurgery services, including movement disorder management. These cities have a higher concentration of healthcare professionals trained in neuromodulation techniques and benefit from ongoing investments in specialized centers and imaging-guided neurosurgery capacity, which contributes to the market's growth. In 2023, the Omani government implemented a regulation mandating that all deep brain stimulation procedures must be performed in accredited healthcare facilities. This regulation is operationalized through the Medical Licensure and Private Health Establishments Regulations issued by the Oman Ministry of Health and enforced by the Directorate General of Private Health Establishments, which require neurosurgical and interventional procedures such as deep brain stimulation to be carried out only in licensed hospitals that meet defined standards for staffing, equipment, and patient safety systems.
Oman Deep Brain Stimulation Parkinsons Disease Market Segmentation
By DBS Target: The market is segmented based on the target areas for deep brain stimulation, which include the Subthalamic Nucleus (STN), Globus Pallidus Internus (GPi), Ventral Intermediate Nucleus (VIM), and others. The Subthalamic Nucleus (STN) is the leading target area due to its demonstrated effectiveness in alleviating motor symptoms associated with Parkinson's disease and its widespread adoption as the preferred target in international clinical practice. The GPi and VIM are also significant but are used less frequently in Parkinson’s disease, with VIM more often selected for essential tremor and other tremor syndromes. The choice of target area is influenced by the specific symptom profile of the patient (such as tremor-dominant versus dyskinesia or rigidity), comorbidities, and the expertise and protocol preferences of the treating neurologist and neurosurgical team. By Product Type: The product type segmentation includes Single-channel DBS Systems, Dual-channel DBS Systems, Software and Programming Systems, and Accessories. In the global market, Dual-channel DBS Systems account for the larger share as they enable bilateral stimulation and more sophisticated programming, and this global preference increasingly influences product adoption patterns in Oman. Single-channel DBS Systems remain widely used where unilateral procedures or cost-sensitive procurement is prioritized, while software and programming systems are essential for device optimization, remote adjustment, and battery management and are bundled with major platforms. Accessories, although important for surgical implantation, lead management, and system replacement, represent a smaller segment of the market.
Oman Deep Brain Stimulation Parkinsons Disease Market Market Opportunities
The Oman Deep Brain Stimulation Parkinsons Disease Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories (including St. Jude Medical), Aleva Neurotherapeutics SA, Beijing Pins Medical Co., Ltd., SceneRay Co., Ltd., NeuroPace, Inc., Functional Neuromodulation Ltd., NeuroSigma, Inc., Synapse Biomedical Inc., Aleva Neurotherapeutics SA, Newronika S.p.A., Axonics, Inc., Nevro Corp., Zynex Medical, Inc. contribute to innovation, geographic expansion, and service delivery in this space.
Medtronic plc
1949 Minneapolis, Minnesota, USA
Boston Scientific Corporation
1979 Marlborough, Massachusetts, USA
Abbott Laboratories
1888 Abbott Park, Illinois, USA
Aleva Neurotherapeutics SA
2008 Lausanne, Switzerland
Beijing Pins Medical Co., Ltd. 2008 Beijing, China
Company
Establishment Year
Headquarters
Group Size (Large, Medium, or Small as per industry convention)
Oman DBS Revenue (USD Million)
3-year CAGR in Oman DBS Revenue
Oman Parkinson’s DBS Installed Base
New DBS Implants per Year in Oman
Oman Market Share in Parkinson’s DBS (%)
Oman Deep Brain Stimulation Parkinsons Disease Market Industry Analysis
Growth Drivers
Increasing Prevalence of Parkinson's Disease: The prevalence of Parkinson's Disease in Oman is estimated to be around 15,000 cases, reflecting a significant rise due to an aging population. According to the World Health Organization, the number of individuals aged 60 and above in Oman is projected to reach 1.3 million in future. This demographic shift is expected to drive demand for deep brain stimulation (DBS) treatments, as older adults are more susceptible to neurological disorders, including Parkinson's Disease. Advancements in Deep Brain Stimulation Technology: The deep brain stimulation technology has seen substantial advancements, with new devices offering improved efficacy and safety profiles. In future, the introduction of closed-loop DBS systems is anticipated, which can adapt stimulation based on real-time brain activity. This innovation is supported by a 25% increase in R&D spending in the medical device sector in Oman, fostering a conducive environment for technological breakthroughs that enhance treatment outcomes for Parkinson's patients. Growing Awareness and Acceptance of DBS Treatments: Awareness campaigns led by healthcare organizations have increased public knowledge about DBS as a viable treatment for Parkinson's Disease. In future, approximately 65% of neurologists in Oman report a rise in patient inquiries regarding DBS options. This growing acceptance is further bolstered by patient advocacy groups, which have increased outreach efforts, leading to a 35% increase in the number of patients seeking consultations for DBS procedures in the past year.
Market Challenges
High Cost of Deep Brain Stimulation Procedures: The average cost of a deep brain stimulation procedure in Oman is approximately OMR 16,000 (around USD 41,600), which poses a significant barrier for many patients. With the average annual income in Oman being around OMR 9,000 (USD 23,400), the financial burden of DBS procedures can deter patients from pursuing this treatment option. This challenge is exacerbated by limited insurance coverage for such advanced medical interventions. Limited Access to Specialized Healthcare Facilities: Access to specialized healthcare facilities offering DBS procedures is limited, with only four centers in Oman equipped to perform these surgeries. In future, the population-to-specialist ratio stands at 1 neurologist per 45,000 people, significantly hindering timely access to care. This scarcity of resources can lead to delays in treatment, adversely affecting patient outcomes and overall market growth in the region.
Oman Deep Brain Stimulation Parkinsons Disease Market Future Outlook
The future of the deep brain stimulation market in Oman appears promising, driven by ongoing advancements in technology and increasing healthcare investments. As the government allocates more resources to enhance neurological care, the number of DBS procedures is expected to rise significantly in future. Additionally, the integration of telemedicine and AI in patient management will likely improve access and efficiency, fostering a more robust healthcare ecosystem that supports Parkinson's Disease patients in Oman.
Market Opportunities
Expansion of Healthcare Infrastructure: The Omani government is investing over OMR 1.5 billion (USD 3.9 billion) in healthcare infrastructure in future. This investment aims to enhance access to specialized care, including DBS procedures, thereby creating a favorable environment for market growth and improved patient outcomes. Increasing Investment in Neurological Research: With a projected increase of 20% in funding for neurological research in Oman, collaborations with international research institutions are expected to yield innovative treatment options. This influx of investment will likely accelerate the development of advanced DBS technologies, enhancing treatment efficacy and patient care.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
The Oman Deep Brain Stimulation market is valued at USD 40 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of Parkinson's disease, the growing burden of neurological disorders in the Middle East, advancements in deep brain stimulation devices (such as rechargeable and directional leads), and rising awareness about neuromodulation treatment options among patients and healthcare providers. Muscat and Dhofar are the dominant regions in the Oman Deep Brain Stimulation market due to their advanced healthcare infrastructure and the presence of tertiary and university hospitals that provide neurology and neurosurgery services, including movement disorder management. These cities have a higher concentration of healthcare professionals trained in neuromodulation techniques and benefit from ongoing investments in specialized centers and imaging-guided neurosurgery capacity, which contributes to the market's growth. In 2023, the Omani government implemented a regulation mandating that all deep brain stimulation procedures must be performed in accredited healthcare facilities. This regulation is operationalized through the Medical Licensure and Private Health Establishments Regulations issued by the Oman Ministry of Health and enforced by the Directorate General of Private Health Establishments, which require neurosurgical and interventional procedures such as deep brain stimulation to be carried out only in licensed hospitals that meet defined standards for staffing, equipment, and patient safety systems.
Oman Deep Brain Stimulation Parkinsons Disease Market Segmentation
By DBS Target: The market is segmented based on the target areas for deep brain stimulation, which include the Subthalamic Nucleus (STN), Globus Pallidus Internus (GPi), Ventral Intermediate Nucleus (VIM), and others. The Subthalamic Nucleus (STN) is the leading target area due to its demonstrated effectiveness in alleviating motor symptoms associated with Parkinson's disease and its widespread adoption as the preferred target in international clinical practice. The GPi and VIM are also significant but are used less frequently in Parkinson’s disease, with VIM more often selected for essential tremor and other tremor syndromes. The choice of target area is influenced by the specific symptom profile of the patient (such as tremor-dominant versus dyskinesia or rigidity), comorbidities, and the expertise and protocol preferences of the treating neurologist and neurosurgical team. By Product Type: The product type segmentation includes Single-channel DBS Systems, Dual-channel DBS Systems, Software and Programming Systems, and Accessories. In the global market, Dual-channel DBS Systems account for the larger share as they enable bilateral stimulation and more sophisticated programming, and this global preference increasingly influences product adoption patterns in Oman. Single-channel DBS Systems remain widely used where unilateral procedures or cost-sensitive procurement is prioritized, while software and programming systems are essential for device optimization, remote adjustment, and battery management and are bundled with major platforms. Accessories, although important for surgical implantation, lead management, and system replacement, represent a smaller segment of the market.
Oman Deep Brain Stimulation Parkinsons Disease Market Market Opportunities
The Oman Deep Brain Stimulation Parkinsons Disease Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories (including St. Jude Medical), Aleva Neurotherapeutics SA, Beijing Pins Medical Co., Ltd., SceneRay Co., Ltd., NeuroPace, Inc., Functional Neuromodulation Ltd., NeuroSigma, Inc., Synapse Biomedical Inc., Aleva Neurotherapeutics SA, Newronika S.p.A., Axonics, Inc., Nevro Corp., Zynex Medical, Inc. contribute to innovation, geographic expansion, and service delivery in this space.
Medtronic plc
1949 Minneapolis, Minnesota, USA
Boston Scientific Corporation
1979 Marlborough, Massachusetts, USA
Abbott Laboratories
1888 Abbott Park, Illinois, USA
Aleva Neurotherapeutics SA
2008 Lausanne, Switzerland
Beijing Pins Medical Co., Ltd. 2008 Beijing, China
Company
Establishment Year
Headquarters
Group Size (Large, Medium, or Small as per industry convention)
Oman DBS Revenue (USD Million)
3-year CAGR in Oman DBS Revenue
Oman Parkinson’s DBS Installed Base
New DBS Implants per Year in Oman
Oman Market Share in Parkinson’s DBS (%)
Oman Deep Brain Stimulation Parkinsons Disease Market Industry Analysis
Growth Drivers
Increasing Prevalence of Parkinson's Disease: The prevalence of Parkinson's Disease in Oman is estimated to be around 15,000 cases, reflecting a significant rise due to an aging population. According to the World Health Organization, the number of individuals aged 60 and above in Oman is projected to reach 1.3 million in future. This demographic shift is expected to drive demand for deep brain stimulation (DBS) treatments, as older adults are more susceptible to neurological disorders, including Parkinson's Disease. Advancements in Deep Brain Stimulation Technology: The deep brain stimulation technology has seen substantial advancements, with new devices offering improved efficacy and safety profiles. In future, the introduction of closed-loop DBS systems is anticipated, which can adapt stimulation based on real-time brain activity. This innovation is supported by a 25% increase in R&D spending in the medical device sector in Oman, fostering a conducive environment for technological breakthroughs that enhance treatment outcomes for Parkinson's patients. Growing Awareness and Acceptance of DBS Treatments: Awareness campaigns led by healthcare organizations have increased public knowledge about DBS as a viable treatment for Parkinson's Disease. In future, approximately 65% of neurologists in Oman report a rise in patient inquiries regarding DBS options. This growing acceptance is further bolstered by patient advocacy groups, which have increased outreach efforts, leading to a 35% increase in the number of patients seeking consultations for DBS procedures in the past year.
Market Challenges
High Cost of Deep Brain Stimulation Procedures: The average cost of a deep brain stimulation procedure in Oman is approximately OMR 16,000 (around USD 41,600), which poses a significant barrier for many patients. With the average annual income in Oman being around OMR 9,000 (USD 23,400), the financial burden of DBS procedures can deter patients from pursuing this treatment option. This challenge is exacerbated by limited insurance coverage for such advanced medical interventions. Limited Access to Specialized Healthcare Facilities: Access to specialized healthcare facilities offering DBS procedures is limited, with only four centers in Oman equipped to perform these surgeries. In future, the population-to-specialist ratio stands at 1 neurologist per 45,000 people, significantly hindering timely access to care. This scarcity of resources can lead to delays in treatment, adversely affecting patient outcomes and overall market growth in the region.
Oman Deep Brain Stimulation Parkinsons Disease Market Future Outlook
The future of the deep brain stimulation market in Oman appears promising, driven by ongoing advancements in technology and increasing healthcare investments. As the government allocates more resources to enhance neurological care, the number of DBS procedures is expected to rise significantly in future. Additionally, the integration of telemedicine and AI in patient management will likely improve access and efficiency, fostering a more robust healthcare ecosystem that supports Parkinson's Disease patients in Oman.
Market Opportunities
Expansion of Healthcare Infrastructure: The Omani government is investing over OMR 1.5 billion (USD 3.9 billion) in healthcare infrastructure in future. This investment aims to enhance access to specialized care, including DBS procedures, thereby creating a favorable environment for market growth and improved patient outcomes. Increasing Investment in Neurological Research: With a projected increase of 20% in funding for neurological research in Oman, collaborations with international research institutions are expected to yield innovative treatment options. This influx of investment will likely accelerate the development of advanced DBS technologies, enhancing treatment efficacy and patient care.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
92 Pages
- 1. Oman Deep Brain Stimulation Parkinsons Disease Size Share Growth Drivers Trends Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Oman Deep Brain Stimulation Parkinsons Disease Size Share Growth Drivers Trends Opportunities & – Market Size (in USD Bn), 2019-2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Oman Deep Brain Stimulation Parkinsons Disease Size Share Growth Drivers Trends Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1 Increasing prevalence of Parkinson's disease in Oman
- 3.1.2 Advancements in deep brain stimulation technology
- 3.1.3 Rising healthcare expenditure on neurological disorders
- 3.1.4 Government initiatives to enhance Parkinson's disease treatment
- 3.2. Restraints
- 3.2.1 High cost of deep brain stimulation procedures
- 3.2.2 Limited awareness among patients and healthcare providers
- 3.2.3 Regulatory challenges in medical device approvals
- 3.2.4 Shortage of trained healthcare professionals in Oman
- 3.3. Opportunities
- 3.3.1 Expansion of healthcare facilities offering DBS services
- 3.3.2 Collaborations with international medical device manufacturers
- 3.3.3 Increasing investment in neurological research and development
- 3.3.4 Growing patient advocacy for improved treatment options
- 3.4. Trends
- 3.4.1 Shift towards minimally invasive surgical techniques
- 3.4.2 Integration of telemedicine in Parkinson's disease management
- 3.4.3 Rising demand for personalized medicine approaches
- 3.4.4 Increased focus on patient-centered care models
- 3.5. Government Regulation
- 3.5.1 Regulatory frameworks for medical devices in Oman
- 3.5.2 Compliance with international standards for DBS devices
- 3.5.3 Guidelines for clinical trials and research in neurology
- 3.5.4 Policies promoting access to advanced neurological treatments
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Oman Deep Brain Stimulation Parkinsons Disease Size Share Growth Drivers Trends Opportunities & – Market Segmentation, 2024
- 4.1. By Product Type (in Value %)
- 4.1.1 Implantable Pulse Generators
- 4.1.2 Electrodes
- 4.1.3 Accessories
- 4.1.4 Others
- 4.2. By Procedure Type (in Value %)
- 4.2.1 Bilateral DBS
- 4.2.2 Unilateral DBS
- 4.2.3 Others
- 4.3. By End-User (in Value %)
- 4.3.1 Hospitals
- 4.3.2 Specialty Clinics
- 4.3.3 Research Institutions
- 4.4. By Patient Demographics (in Value %)
- 4.4.1 Age Group
- 4.4.2 Gender
- 4.4.3 Others
- 4.5. By Treatment Stage (in Value %)
- 4.5.1 Early Stage
- 4.5.2 Advanced Stage
- 4.5.3 Others
- 4.6. By Region (in Value %)
- 4.6.1 North Oman
- 4.6.2 South Oman
- 4.6.3 East Oman
- 4.6.4 West Oman
- 4.6.5 Central Oman
- 4.6.6 Muscat
- 4.6.7 Dhofar
- 5. Oman Deep Brain Stimulation Parkinsons Disease Size Share Growth Drivers Trends Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1 Medtronic
- 5.1.2 Boston Scientific
- 5.1.3 Abbott Laboratories
- 5.1.4 St. Jude Medical
- 5.1.5 Nevro Corp
- 5.2. Cross Comparison Parameters
- 5.2.1 No. of Employees
- 5.2.2 Headquarters
- 5.2.3 Inception Year
- 5.2.4 Revenue
- 5.2.5 Market Share
- 6. Oman Deep Brain Stimulation Parkinsons Disease Size Share Growth Drivers Trends Opportunities & – Market Regulatory Framework
- 6.1. Medical Device Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Oman Deep Brain Stimulation Parkinsons Disease Size Share Growth Drivers Trends Opportunities & – Market Future Size (in USD Bn), 2025-2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Oman Deep Brain Stimulation Parkinsons Disease Size Share Growth Drivers Trends Opportunities & – Market Future Segmentation, 2030
- 8.1. By Product Type (in Value %)
- 8.2. By Procedure Type (in Value %)
- 8.3. By End-User (in Value %)
- 8.4. By Patient Demographics (in Value %)
- 8.5. By Treatment Stage (in Value %)
- 8.6. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
